USP7 Promotes the Osteoclast Differentiation of CD14+ Human Peripheral Blood Monocytes in Osteoporosis Via HMGB1 Deubiquitination

Overview

Journal J Orthop Translat

Publisher Elsevier

Specialty Orthopedics

Date 2023 Jun 19

PMID 37333461

Authors

Yu-Cong Lin

Guan Zheng

Hua-Tao Liu

Peng Wang

Wei-Quan Yuan

Yun-Hui Zhang

Xiao-Shuai Peng

Guo-Jian Li

Yan-Feng Wu

Hui-Yong Shen

Affiliations

Soon will be listed here.

Abstract

Background: Abnormal osteoclast and osteoblast differentiation is an essential pathological process in osteoporosis. As an important deubiquitinase enzyme, ubiquitin-specific peptidase 7 (USP7) participates in various disease processes through posttranslational modification. However, the mechanism by which USP7 regulates osteoporosis remains unknown. Herein, we aimed to investigate whether USP7 regulates abnormal osteoclast differentiation in osteoporosis.

Methods: The gene expression profiles of blood monocytes were preprocessed to analyze the differential expression of USP genes. CD14+ peripheral blood mononuclear cells (PBMCs) were isolated from whole blood collected from osteoporosis patients (OPs) and healthy donors (HDs), and the expression pattern of USP7 during the differentiation of CD14+ PBMCs into osteoclasts was detected by western blotting. The role of USP7 in the osteoclast differentiation of PBMCs treated with USP7 siRNA or exogenous rUSP7 was further investigated by the F-actin assay, TRAP staining and western blotting. Moreover, the interaction between high-mobility group protein 1 (HMGB1) and USP7 was investigated by coimmunoprecipitation, and the regulation of the USP7-HMGB1 axis in osteoclast differentiation was further verified. Osteoporosis in ovariectomized (OVX) mice was then studied using the USP7-specific inhibitor P5091 to identify the role of USP7 in osteoporosis.

Results: The bioinformatic analyses and CD14+ PBMCs from osteoporosis patients confirmed that the upregulation of USP7 was associated with osteoporosis. USP7 positively regulates the osteoclast differentiation of CD14+ PBMCs in vitro. Mechanistically, USP7 promoted osteoclast formation by binding to and deubiquitination of HMGB1. In vivo, P5091 effectively attenuates bone loss in OVX mice.

Conclusion: We demonstrate that USP7 promotes the differentiation of CD14+ PBMCs into osteoclasts via HMGB1 deubiquitination and that inhibition of USP7 effectively attenuates bone loss in osteoporosis in vivo.:The study reveals novel insights into the role of USP7 in the progression of osteoporosis and provides a new therapeutic target for the treatment of osteoporosis.

Citing Articles

USP7 Inhibition Promotes Early Osseointegration in Senile Osteoporotic Mice.

Zhou F, Wang Z, Li H, Wang D, Wu Z, Bai F J Dent Res. 2024; 104(1):86-96.

PMID: 39651622 PMC: 11667195. DOI: 10.1177/00220345241288570.

Peripheral inflammatory T cell subsets are effective predictive factors in the development of heterotopic ossification after posttraumatic elbow surgery.

Xin Z, Chen J, Huang F, Guo S, Yao Y, Tang Y Heliyon. 2024; 10(13):e33851.

PMID: 39055826 PMC: 11269831. DOI: 10.1016/j.heliyon.2024.e33851.

Role of ubiquitination in the occurrence and development of osteoporosis (Review).

Fan X, Zhang R, Xu G, Fan P, Luo W, Cai C Int J Mol Med. 2024; 54(2).

PMID: 38940355 PMC: 11232666. DOI: 10.3892/ijmm.2024.5392.

Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment.

Lelarge V, Capelle R, Oger F, Mathieu T, Le Calve B NPJ Aging. 2024; 10(1):12.

PMID: 38321020 PMC: 10847408. DOI: 10.1038/s41514-024-00138-4.

Deubiquitinase USP17 Regulates Osteoblast Differentiation by Increasing Osterix Protein Stability.

Kim M, Piao M, Li Y, Lee S, Lee K Int J Mol Sci. 2023; 24(20).

PMID: 37894935 PMC: 10607737. DOI: 10.3390/ijms242015257.

References

Pohl C, Dikic I . Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019; 366(6467):818-822. DOI: 10.1126/science.aax3769. View

Massey H, Flanagan A . Human osteoclasts derive from CD14-positive monocytes. Br J Haematol. 1999; 106(1):167-70. DOI: 10.1046/j.1365-2141.1999.01491.x. View

Xiao Y, Huang Q, Wu Z, Chen W . Roles of protein ubiquitination in inflammatory bowel disease. Immunobiology. 2020; 225(6):152026. DOI: 10.1016/j.imbio.2020.152026. View

Komori T . Animal models for osteoporosis. Eur J Pharmacol. 2015; 759:287-94. DOI: 10.1016/j.ejphar.2015.03.028. View

Ji L, Lu B, Zamponi R, Charlat O, Aversa R, Yang Z . USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin. Nat Commun. 2019; 10(1):4184. PMC: 6744515. DOI: 10.1038/s41467-019-12143-3. View

Qiu Z, Li L, Huang Y, Shi K, Zhang L, Huang C . Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway. J Orthop Translat. 2022; 33:55-69. PMC: 8858883. DOI: 10.1016/j.jot.2022.01.003. View

Ang E, Pavlos N, Rea S, Qi M, Chai T, Walsh J . Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascades. J Cell Physiol. 2009; 220(2):450-9. DOI: 10.1002/jcp.21787. View

Hitt A, Laing S, Olson S . Development of a fluorescent F-actin blot overlay assay for detection of F-actin binding proteins. Anal Biochem. 2002; 310(1):67-71. DOI: 10.1016/s0003-2697(02)00280-4. View

Cen S, Wang P, Xie Z, Yang R, Li J, Liu Z . Autophagy enhances mesenchymal stem cell-mediated CD4 T cell migration and differentiation through CXCL8 and TGF-β1. Stem Cell Res Ther. 2019; 10(1):265. PMC: 6708254. DOI: 10.1186/s13287-019-1380-0. View

10.

Okamoto K, Nakashima T, Shinohara M, Negishi-Koga T, Komatsu N, Terashima A . Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. Physiol Rev. 2017; 97(4):1295-1349. DOI: 10.1152/physrev.00036.2016. View

11.

Li Q, Wang M, Xue H, Liu W, Guo Y, Xu R . Ubiquitin-Specific Protease 34 Inhibits Osteoclast Differentiation by Regulating NF-κB Signaling. J Bone Miner Res. 2020; 35(8):1597-1608. DOI: 10.1002/jbmr.4015. View

12.

Huang C, Zheng Y, Bai J, Shi C, Shi X, Shan H . Hepatocyte growth factor overexpression promotes osteoclastogenesis and exacerbates bone loss in CIA mice. J Orthop Translat. 2020; 27:9-16. PMC: 7732867. DOI: 10.1016/j.jot.2020.10.011. View

13.

Nininahazwe L, Liu B, He C, Zhang H, Chen Z . The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy. Drug Discov Today. 2020; 26(2):490-502. DOI: 10.1016/j.drudis.2020.10.028. View

14.

Rousseau A, Bertolotti A . Regulation of proteasome assembly and activity in health and disease. Nat Rev Mol Cell Biol. 2018; 19(11):697-712. DOI: 10.1038/s41580-018-0040-z. View

15.

Drake M, Clarke B, Khosla S . Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008; 83(9):1032-45. PMC: 2667901. DOI: 10.4065/83.9.1032. View

16.

Song X, Wang S, Li L . New insights into the regulation of Axin function in canonical Wnt signaling pathway. Protein Cell. 2014; 5(3):186-93. PMC: 3967064. DOI: 10.1007/s13238-014-0019-2. View

17.

Jin W, Chang M, Paul E, Babu G, Lee A, Reiley W . Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J Clin Invest. 2008; 118(5):1858-66. PMC: 2276399. DOI: 10.1172/JCI34257. View

18.

Yang D, Wan Y . Molecular determinants for the polarization of macrophage and osteoclast. Semin Immunopathol. 2019; 41(5):551-563. PMC: 6815265. DOI: 10.1007/s00281-019-00754-3. View

19.

Kim J, Lin C, Stavre Z, Greenblatt M, Shim J . Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells. 2020; 9(9). PMC: 7564526. DOI: 10.3390/cells9092073. View

20.

Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View